Hella Kohlhof
Chief Scientific Officer Immunic Therapeutics
Seminars
Friday 12th December 2025
Vidodfludimus Calcium Uniquely Combines Direct Neuroprotective & Anti-inflammatory Properties for the Treatment of Multiple Sclerosis
12:00 pm
- Combining neuroprotection and relapse prevention by targeting the neuroprotective factor Nurr1 and anti-inflammatory target DHODH
- Addressing neuronal function as a potential therapy for both relapsing and progressive forms of neurodegenerative diseases
- Investigating Nurr1 as a relevant target to treat different neurodegenerative diseases
